Annual Cash & Cash Equivalents
$884.40 K
-$829.40 K-48.40%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual cash & cash equivalents is $884.40 thousand, with the most recent change of -$829.40 thousand (-48.40%) on December 1, 2023.
- During the last 3 years, BRTX annual cash & cash equivalents has fallen by -$2.18 million (-71.14%).
- BRTX annual cash & cash equivalents is now -95.79% below its all-time high of $21.03 million, reached on December 31, 2021.
Performance
BRTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.49 M
-$762.80 K-33.87%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly cash and cash equivalents is $1.49 million, with the most recent change of -$762.80 thousand (-33.87%) on September 1, 2024.
- Over the past year, BRTX quarterly cash and cash equivalents has dropped by -$947.50 thousand (-38.88%).
- BRTX quarterly cash and cash equivalents is now -92.92% below its all-time high of $21.03 million, reached on December 31, 2021.
Performance
BRTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BRTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.4% | -38.9% |
| 3 y3 years | -71.1% | -92.9% |
| 5 y5 years | +652.7% | -92.9% |
BRTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.8% | at low | -92.9% | +68.4% |
| 5 y | 5-year | -95.8% | >+9999.0% | -92.9% | >+9999.0% |
| alltime | all time | -95.8% | >+9999.0% | -92.9% | >+9999.0% |
BioRestorative Therapies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.49 M(-33.9%) |
| Jun 2024 | - | $2.25 M(+94.6%) |
| Mar 2024 | - | $1.16 M(+30.8%) |
| Dec 2023 | $884.40 K(-48.4%) | $884.40 K(-63.7%) |
| Sep 2023 | - | $2.44 M(+36.6%) |
| Jun 2023 | - | $1.78 M(-2.9%) |
| Mar 2023 | - | $1.84 M(+7.2%) |
| Dec 2022 | $1.71 M(-91.8%) | $1.71 M(-73.9%) |
| Sep 2022 | - | $6.57 M(-63.3%) |
| Jun 2022 | - | $17.93 M(-7.2%) |
| Mar 2022 | - | $19.32 M(-8.1%) |
| Dec 2021 | $21.03 M(+586.1%) | $21.03 M(+1761.3%) |
| Sep 2021 | - | $1.13 M(-35.8%) |
| Jun 2021 | - | $1.76 M(-29.7%) |
| Mar 2021 | - | $2.50 M(-18.4%) |
| Dec 2020 | $3.06 M(>+9900.0%) | $3.06 M(+1641.3%) |
| Sep 2020 | - | $176.00 K(-41.0%) |
| Jun 2020 | - | $298.10 K(+6110.4%) |
| Mar 2020 | - | $4800.00(+182.4%) |
| Dec 2019 | $1700.00(-98.6%) | $1700.00(-98.3%) |
| Sep 2019 | - | $98.10 K(-92.4%) |
| Jun 2019 | - | $1.28 M(+158.7%) |
| Mar 2019 | - | $496.30 K(+322.4%) |
| Dec 2018 | $117.50 K(-74.0%) | $117.50 K(+11.5%) |
| Sep 2018 | - | $105.40 K(+2911.4%) |
| Jun 2018 | - | $3500.00(-59.3%) |
| Mar 2018 | - | $8600.00(-98.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $451.70 K(+1320.4%) | $451.70 K(>+9900.0%) |
| Sep 2017 | - | $700.00(-63.2%) |
| Jun 2017 | - | $1900.00(-78.7%) |
| Mar 2017 | - | $8900.00(-72.0%) |
| Dec 2016 | $31.80 K(-80.9%) | $31.80 K(+404.8%) |
| Sep 2016 | - | $6300.00(-98.8%) |
| Jun 2016 | - | $516.20 K(+46.2%) |
| Mar 2016 | - | $353.10 K(+111.9%) |
| Dec 2015 | $166.60 K(+81.5%) | $166.60 K(+1201.6%) |
| Sep 2015 | - | $12.80 K(+100.0%) |
| Jun 2015 | - | $6400.00(-95.6%) |
| Mar 2015 | - | $145.90 K(+58.9%) |
| Dec 2014 | $91.80 K(-54.4%) | $91.80 K(-75.5%) |
| Sep 2014 | - | $374.00 K(+531.8%) |
| Jun 2014 | - | $59.20 K(-46.4%) |
| Mar 2014 | - | $110.40 K(-45.1%) |
| Dec 2013 | $201.10 K(>+9900.0%) | $201.10 K(>+9900.0%) |
| Sep 2013 | - | $600.00(+500.0%) |
| Jun 2013 | - | $100.00(-100.0%) |
| Mar 2013 | - | $498.60 K(>+9900.0%) |
| Dec 2012 | $400.00(-99.4%) | $400.00(-99.6%) |
| Sep 2012 | - | $104.10 K(+726.2%) |
| Jun 2012 | - | $12.60 K(+306.5%) |
| Mar 2012 | - | $3100.00(-95.7%) |
| Dec 2011 | $71.50 K(+295.0%) | $71.50 K(+389.7%) |
| Sep 2011 | - | $14.60 K(-19.3%) |
| Dec 2010 | $18.10 K | $18.10 K |
FAQ
- What is BioRestorative Therapies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioRestorative Therapies?
- What is BioRestorative Therapies annual cash & cash equivalents year-on-year change?
- What is BioRestorative Therapies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly cash and cash equivalents year-on-year change?
What is BioRestorative Therapies annual cash & cash equivalents?
The current annual cash & cash equivalents of BRTX is $884.40 K
What is the all time high annual cash & cash equivalents for BioRestorative Therapies?
BioRestorative Therapies all-time high annual cash & cash equivalents is $21.03 M
What is BioRestorative Therapies annual cash & cash equivalents year-on-year change?
Over the past year, BRTX annual cash & cash equivalents has changed by -$829.40 K (-48.40%)
What is BioRestorative Therapies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BRTX is $1.49 M
What is the all time high quarterly cash and cash equivalents for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly cash and cash equivalents is $21.03 M
What is BioRestorative Therapies quarterly cash and cash equivalents year-on-year change?
Over the past year, BRTX quarterly cash and cash equivalents has changed by -$947.50 K (-38.88%)